Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond P Goodrich

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Transfusion|May 26, 2012
Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology systemDana L Vanlandingham, Shawn D Keil, Kate McElroy Horne, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2011
Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°CAnna Ettinger, Meghan M Miklauz, Brianna K Hendrix, et al.
Transfusion|August 11, 2011
Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole bloodLaura Tonnetti, Aaron M Thorp, Heather L Reddy, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 22, 2011
Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °CAnna Ettinger, Meghan M Miklauz, Brianna K Hendrix, et al.
Transfusion|July 19, 2012
Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole bloodLaura Tonnetti, Aaron M Thorp, Heather L Reddy, et al.
Transfusion|August 5, 2005
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reductionJames P AuBuchon, Louise Herschel, Jill Roger, et al.
Transfusion|December 9, 2015
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cellsChristopher A Tormey, Manjula Santhanakrishnan, Nicole H Smith, et al.
Lancet (London, England)|April 27, 2016
Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trialJean-Pierre Allain, Alex K Owusu-Ofori, Sonny Michael Assennato, et al.
Transfusion|January 17, 2013
Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet lightShawn D Keil, Patti Kiser, James J Sullivan, et al.
Transfusion|May 12, 2010
In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technologySisse R Ostrowski, Louise Bochsen, José A Salado-Jimena, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Transfusion|May 26, 2012
Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology systemDana L Vanlandingham, Shawn D Keil, Kate McElroy Horne, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 26, 2011
Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°CAnna Ettinger, Meghan M Miklauz, Brianna K Hendrix, et al.
Transfusion|August 11, 2011
Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole bloodLaura Tonnetti, Aaron M Thorp, Heather L Reddy, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 22, 2011
Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °CAnna Ettinger, Meghan M Miklauz, Brianna K Hendrix, et al.
Transfusion|July 19, 2012
Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole bloodLaura Tonnetti, Aaron M Thorp, Heather L Reddy, et al.
Transfusion|August 5, 2005
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reductionJames P AuBuchon, Louise Herschel, Jill Roger, et al.
Transfusion|December 9, 2015
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cellsChristopher A Tormey, Manjula Santhanakrishnan, Nicole H Smith, et al.
Lancet (London, England)|April 27, 2016
Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trialJean-Pierre Allain, Alex K Owusu-Ofori, Sonny Michael Assennato, et al.
Transfusion|January 17, 2013
Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet lightShawn D Keil, Patti Kiser, James J Sullivan, et al.
Transfusion|May 12, 2010
In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technologySisse R Ostrowski, Louise Bochsen, José A Salado-Jimena, et al.
Pageof 7